miR-492 Promotes Cancer Progression by Targeting GJB4 and Is a Novel Biomarker for Bladder Cancer.

MLA

Wang, Kai, et al. “MiR-492 Promotes Cancer Progression by Targeting GJB4 and Is a Novel Biomarker for Bladder Cancer.” OncoTargets & Therapy, vol. 12, Dec. 2019, pp. 11453–64. EBSCOhost, https://doi.org/10.2147/OTT.S223448.

APA

Wang, K., Lü, H., Qu, H., Xie, Q., Sun, T., Gan, O., & Hu, B. (2019). miR-492 Promotes Cancer Progression by Targeting GJB4 and Is a Novel Biomarker for Bladder Cancer. OncoTargets & Therapy, 12, 11453–11464. https://doi.org/10.2147/OTT.S223448

Chicago

Wang, Kai, Hang Lü, Hongchen Qu, Qingpeng Xie, Tao Sun, Ou Gan, and Bin Hu. 2019. “MiR-492 Promotes Cancer Progression by Targeting GJB4 and Is a Novel Biomarker for Bladder Cancer.” OncoTargets & Therapy 12 (December): 11453–64. doi:10.2147/OTT.S223448.